Hydrastinine hydrochloride

CAS No. 4884-68-8

Hydrastinine hydrochloride( —— )

Catalog No. M19418 CAS No. 4884-68-8

Hydrastinine hydrochloride is a semisynthetic alkaloid from the hydrolysis of the alkaloid Hydrastine used as a haemostatic drug.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 90 In Stock
25MG 162 In Stock
50MG 279 In Stock
100MG 459 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hydrastinine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Hydrastinine hydrochloride is a semisynthetic alkaloid from the hydrolysis of the alkaloid Hydrastine used as a haemostatic drug.
  • Description
    Hydrastinine hydrochloride is a semisynthetic alkaloid from the hydrolysis of the alkaloid Hydrastine used as a haemostatic drug.
  • In Vitro
    Goldenseal has been used for the treatment of a wide variety of ailments including gastrointestinal disturbances, urinary tract disorders, and inflammation. The five major alkaloid constituents in goldenseal are Berberine, Palmatine, Hydrastine, Hydrastinine, and Canadine.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4884-68-8
  • Formula Weight
    225.67
  • Molecular Formula
    C11H12ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    Water:10 mM
  • SMILES
    CN1CCC2=CC3=C(C=C2C1O)OCO3.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.POE CF JOHNSON CC. Acta Pharmacol Toxicol (Copenh). 1954; 10(4):338-46.
molnova catalog
related products
  • TGFβRI-IN-3

    TGFβRI-IN-3 is a highly selective TGFβR1 inhibitor with an IC50 of 0.79 nM and exhibits 2000-fold selectivity against MAP4K4, showing potential applications in immuno-oncology .

  • Compound 35

    Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses.Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9.

  • Glycodeoxycholic aci...

    Glycodeoxycholic Acid induces apoptosis in hepatocytes by a mechanism associated with DNA cleavage by endonucleases. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment.